Abstract
Background
Autosomal recessive corneal hereditary endothelial dystrophy (CHED) is a rare congenital disorder of cornea. Mutations in SLC4A11 gene are associated with CHED phenotype. CHED is also an early feature of Harboyan syndrome. The aim of the present study was to identify genetic mutations in the SLC4A11 gene in CHED cases belonging to inbred Pakistani families. Furthermore, all homozygous mutation carriers were investigated for hearing deficit.
Methods and results
This study included consanguineous CHED families presented at Al-Shifa Trust Eye Hospital, Rawalpindi, Pakistan from June 2018 to September 2018. DNA was extracted from blood samples. Direct sequencing of SLC4A11 gene was performed. All identified variants were evaluated by in silico programs i.e., SIFT, PolyPhen‐2, and MutationTaster. Pathogenicity of the two identified splice site variants was analyzed by Human Splicing Finder and MaxEnt Scan. Screening of five CHED families revealed a total of three previously un reported (p.Arg128Gly, c.2241-2A > T and c.1898-2A > C in family CHED19, CHED22 and CHED26 respectively) and two already reported homozygous disease causing variants (p.Arg869Cys and p.Val824Met in family CHED24 and CHED25 respectively) as predicted by mutation taster. All of these variants segregated with disease phenotype and were not detected in controls.
Conclusion
Affected individuals of the five CHED families screened in this study had the disease due to SLC4A11 mutations and progressing to Harboyan syndrome. Identification of previously unreported mutations aid to heterogeneity of SLC4A11 and CHED pathogenesis as well as helped to provide genetic counseling to affected families.



Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.Data availability
All data relevant to the study are included in the manuscript.
Code availability
Not applicable.
References
Patel SP, Parker MD (2015) SLC4A11 and the pathophysiology of congenital hereditary endothelial dystrophy. Biomed Res Int 2015:475392. https://doi.org/10.1155/2015/475392
Desir J, Abramowicz M (2008) Congenital hereditary endothelial dystrophy with progressive sensorineural deafness (Harboyan syndrome). Orphanet J Rare Dis 3:28. https://doi.org/10.1186/1750-1172-3-28
Toma NM, Ebenezer ND, Inglehearn CF, Plant C, Ficker LA, Bhattacharya SS (1995) Linkage of congenital hereditary endothelial dystrophy to chromosome 20. Hum Mol Genet 4:2395–2398. https://doi.org/10.1093/hmg/4.12.2395
Mohamed MD, McKibbin M, Jafri H, Rasheed Y, Woods CG, Inglehearn CF (2001) A new pedigree with recessive mapping to CHED2 locus on 20p13. Br J Ophthalmol 85:758–759. https://doi.org/10.1136/bjo.85.6.754d
Aldave AJ, Han J, Frausto RF (2013) Genetics of the corneal endothelial dystrophies: an evidence-based review. Clin Genet 84:109–119. https://doi.org/10.1111/cge.12191
Weiss JS, Moller HU, Aldave AJ et al (2015) IC3D classification of corneal dystrophies–edition 2. Cornea 34:117–159. https://doi.org/10.1097/ICO.0000000000000307
Kaul H, Suman M, Khan Z, Ullah MI, Ashfaq UA, Idrees S (2016) Missense mutation in SLC4A11 in two Pakistani families affected with congenital hereditary endothelial dystrophy (CHED2). Clin Exp Optom 99:73–77. https://doi.org/10.1111/cxo.12276
Vilas GL, Loganathan SK, Quon A, Sundaresan P, Vithana EN, Casey J (2012) Oligomerization of SLC4A11 protein and the severity of FECD and CHED2 corneal dystrophies caused by SLC4A11 mutations. Hum Mutat 33:419–428. https://doi.org/10.1002/humu.21655
Malhotra D, Loganathan SK, Chiu AM, Lukowski CM, Casey JR (2019) Human corneal expression of SLC4A11, a gene mutated in endothelial corneal dystrophies. Sci Rep 9:9681. https://doi.org/10.1038/s41598-019-46094-y
Vilas GL, Loganathan SK, Liu J et al (2013) Transmembrane water-flux through SLC4A11: a route defective in genetic corneal diseases. Hum Mol Genet 22:4579–4590. https://doi.org/10.1093/hmg/ddt307
Park M, Li Q, Shcheynikov N, Zeng W, Muallem S (2004) NaBC1 is a ubiquitous electrogenic Na+ -coupled borate transporter essential for cellular boron homeostasis and cell growth and proliferation. Mol Cell 16:331–341. https://doi.org/10.1016/j.molcel.2004.09.030
Ogando DG, Jalimarada SS, Zhang W, Vithana EN, Bonanno JA (2013) SLC4A11 is an EIPA-sensitive Na(+) permeable pHi regulator. Am J Physiol Cell Physiol 305:C716-727. https://doi.org/10.1152/ajpcell.00056.2013
Zhang W, Ogando DG, Bonanno JA, Obukhov AG (2015) Human SLC4A11 is a novel NH3/H+ co-transporter. J Biol Chem 290:16894–16905
Myers EJ, Marshall A, Jennings ML, Parker MD (2016) Mouse Slc4a11 expressed in Xenopus oocytes is an ideally selective H+/OH− conductance pathway that is stimulated by rises in intracellular and extracellular pH. Am J Physiol
Siddiqui S, Zenteno JC, Rice A et al (2014) Congenital hereditary endothelial dystrophy caused by SLC4A11 mutations progresses to Harboyan syndrome. Cornea 33:247–251. https://doi.org/10.1097/ICO.0000000000000041
World Medical A (2013) World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191–2194. https://doi.org/10.1001/jama.2013.281053
Kaul H, Riazuddin SA, Shahid M et al (2010) Autosomal recessive congenital cataract linked to EPHA2 in a consanguineous Pakistani family. Mol Vis 16:511–517
Vis JK, Vermaat M, Taschner PE, Kok JN, Laros JF (2015) An efficient algorithm for the extraction of HGVS variant descriptions from sequences. Bioinformatics 31:3751–3757. https://doi.org/10.1093/bioinformatics/btv443
Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C (2009) Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucl Acids Res 37:e67. https://doi.org/10.1093/nar/gkp215
Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003) ESEfinder: a web resource to identify exonic splicing enhancers. Nucl Acids Res 31:3568–3571. https://doi.org/10.1093/nar/gkg616
Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A (2003) ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucl Acids Res 31:3784–3788. https://doi.org/10.1093/nar/gkg563
Gasteiger E, Hoogland C, Gattiker A, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. The proteomics protocols handbook. Springer, New York, pp 571–607
Desir J, Moya G, Reish O et al (2007) Borate transporter SLC4A11 mutations cause both Harboyan syndrome and non-syndromic corneal endothelial dystrophy. J Med Genet 44:322–326. https://doi.org/10.1136/jmg.2006.046904
Loganathan SK, Lukowski CM, Casey JR (2016) The cytoplasmic domain is essential for transport function of the integral membrane transport protein SLC4A11. Am J Physiol Cell Physiol 310:C161-174. https://doi.org/10.1152/ajpcell.00246.2015
Badior KE, Alka K, Casey JR (2017) SLC4A11 three-dimensional homology model rationalizes corneal dystrophy-causing mutations. Hum Mutat 38:279–288
Loganathan SK, Casey JR (2014) Corneal dystrophy-causing SLC 4 A 11 mutants: suitability for folding-correction therapy. Hum Mutat 35:1082–1091
Vithana EN, Morgan P, Sundaresan P et al (2006) Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). Nat Genet 38:755–757. https://doi.org/10.1038/ng1824
Mehta JS, Hemadevi B, Vithana EN et al (2010) Absence of phenotype-genotype correlation of patients expressing mutations in the SLC4A11 gene. Cornea 29:302–306
Paliwal P, Sharma A, Tandon R et al (2010) Congenital hereditary endothelial dystrophy-mutation analysis of SLC4A11 and genotype-phenotype correlation in a North Indian patient cohort. Mol Vis 16:2955
Harboyan G, Mamo J, Kaloustian Vd, Karam F (1971) Congenital corneal dystrophy. Progressive sensorineural deafness in a family. Arch Ophthalmol 85:27–32. https://doi.org/10.1001/archopht.1971.00990050029005
Chen M, Manley JL (2009) Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 10:741
Abril JF, Castelo R, Guigó R (2005) Comparison of splice sites in mammals and chicken. Genome Res 15:111–119
Mattioli C, Pianigiani G, De Rocco D, Bianco AMR, Cappelli E, Savoia A, Pagani F (2014) Unusual splice site mutations disrupt FANCA exon 8 definition. Biochim Biophys Acta 1842:1052–1058
Gregersen N, Bross P, Jørgensen MM, Corydon TJ, Andresen BS (2000) Defective folding and rapid degradation of mutant proteins is a common disease mechanism in genetic disorders. J Inherit Metab Dis 23:441–447
Williams RS, Chasman DI, Hau DD, Hui B, Lau AY, Glover JM (2003) Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations. J Biol Chem 278:53007–53016
Yeo G, Burge CB (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 11:377–394
Vona B, Nanda I, Neuner C, Müller T, Haaf T (2013) Confirmation of GRHL2 as the gene for the DFNA28 locus. Am J Med Genet A 161:2060–2065
Acknowledgements
We thank patients and their families for their participation in this study. We are grateful to Dr. Muhammad Asif Naeem from National Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan, for audiometric analysis of selected cases.
Funding
This study was financially supported (in part) by the University Research Fund (URF) for the year 2018–2019, Quaid-i-Azam University, Islamabad, Pakistan and access to Scientific Instrumentation Program (ASIP), Higher Education Commission, and Islamabad, Pakistan (20-2(10)/ASIP/R&D/HEC/17/000530(CAMB)/18).
Author information
Authors and Affiliations
Contributions
SF, HK and SN contributed to the study conception and design. WAK and US performed clinical analysis. BN, N and DeS collected data. DeS, N, BN and RG performed experiments. DeS, N and SF did data analysis and prepared the first draft of the manuscript. KA, HK and SN commented on previous versions of the manuscript. All authors read and approved the content and submission of the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
We have no conflict of interest.
Consent to participate
Written informed consent was obtained from all the participants included in this study. Furthermore, it is confirmed that written informed consents were signed by the parents/legally authorized representatives of the subjects of the study, who are all minors.
Consent to publish
Not applicable.
Ethical approval
Bioethical Committee (BEC) of Quaid-i-Azam University, Islamabad, Pakistan approved this study.
Human and animal rights
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Firasat, S., Dur-e-Shawar, Khan, W.A. et al. SLC4A11 mutations causative of congenital hereditary endothelial dystrophy (CHED) progressing to Harboyan syndrome in consanguineous Pakistani families. Mol Biol Rep 48, 7467–7476 (2021). https://doi.org/10.1007/s11033-021-06765-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-021-06765-4

